Industry stakeholder meeting on Brexit and operation of centralised procedure for human and veterinary medicines

EventHumanVeterinaryBrexit

French is available via eTranslation, the European Commission's machine translation service.

Translate to French | Important information about machine translation

Date

Lundi, 24 septembre 2018, Journée Entière

Lieu

European Medicines Agency, Amsterdam, the Netherlands

The purpose of this meeting between the European Medicines Agency (EMA) and European Union trade associations is to update industry stakeholders responsible for human and veterinary medicines on EMA's Brexit preparedness activities.

Documents

Agenda – Industry stakeholder meeting on Brexit and operation of centralised procedure for human and veterinary medicinal products

Reference Number: EMA/642642/2018

English (EN) (60.63 Ko - PDF)

Première publication:
Voir

Report of Industry Stakeholder meeting on Brexit and operation of the centralised procedure for human medicinal products

Reference Number: EMA/694143/2018

English (EN) (144.46 Ko - PDF)

Première publication:
Voir

Presentation - Negotiations with the United Kingdom (Stefan Fuehring)

English (EN) (303.43 Ko - PDF)

Première publication:
Voir

Presentation - Operational preparedness for Brexit and next phase of the Business continuity plan (BCP) (Noël Wathion)

English (EN) (131.31 Ko - PDF)

Première publication:
Voir

Presentation - Update on European Medicines Agency Committees’ Operational Preparedness (Monica Dias)

English (EN) (124.47 Ko - PDF)

Première publication:
Voir

Presentation - European Medicines Agency industry survey summary results (Alberto Jimenez,)

English (EN) (232.07 Ko - PDF)

Première publication:
Voir

Presentation - Joint human medicines industry presentation

English (EN) (502.97 Ko - PDF)

Première publication:
Voir

Presentation - Joint veterinary medicines industry presentation

English (EN) (97.72 Ko - PDF)

Première publication:
Voir

Share this page